Friedrich Jung | Radiology | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Dr. Friedrich Jung | Radiology | Best Researcher Award

Brandenburg Technical University | Germany

Professor Dr. Friedrich Jung is a distinguished biomedical scientist renowned for his pioneering contributions to molecular cell biology, biomaterials, and clinical hemorheology. He has built an illustrious career across leading German research institutions, serving in key academic and leadership roles, including as Director of the Institute for Heart and Circulation Research in Dresden and Head of the Department of Biointerface Engineering at the Berlin Brandenburg Center for Regenerative Therapies. With a strong academic foundation in physical and biomedical engineering from RWTH Aachen and Saarland University, he has significantly advanced the understanding of cell–material interactions and blood–biomaterial compatibility. His research interests encompass biomaterial development, molecular mechanisms of vascular responses, regenerative medicine, and translational biotechnologies aimed at improving clinical outcomes. Highly skilled in experimental cell biology, biointerface engineering, and quality management in biomedical systems, he has authored hundreds of peer-reviewed publications, book chapters, and scientific volumes. Professor Jung’s achievements have been recognised with prestigious honours such as the Robin Fahraeus, Otfried-Müller, and Oskar Orth Awards, and he has held leadership positions in European scientific societies. A visionary scholar and mentor, he continues to inspire innovation in biomedical science, bridging engineering and medicine for the advancement of human health and regenerative therapies.

Profile: Scopus

Featured Publications

Siman Cai | Ultrasound | Young Scientist Award

Published on by Cognitive Scientist Awards

Dr. Siman Cai | Ultrasound | Young Scientist Award

Peking Union Medical College Hospital | China

Dr. Siman Cai is a medical ultrasound specialist conducting advanced research in hemodynamic imaging and tumor diagnostics. She has focused on applying multiple innovative ultrasound technologies, including superb microvascular imaging and shear-wave elastography, to evaluate tumor vascular architecture and improve diagnostic accuracy. Her work has contributed to understanding the vascular patterns of gliomas, their differentiation grades, and molecular subtypes, as well as breast lesions, providing valuable quantitative indicators for distinguishing benign and malignant tumors. Dr. Cai has demonstrated the clinical relevance of these imaging modalities in both preoperative and intraoperative settings, enhancing tumor boundary identification and aiding in total tumor resection. Her publications highlight the diagnostic value of vascular indices and imaging-derived markers for precision oncology. Through her work, she has bridged technological innovation with clinical applications, advancing the accuracy of tumor diagnosis and the effectiveness of treatment planning in neuro-oncology and breast cancer imaging.

Profile

ORCID

Education

Dr. Siman Cai received her professional doctorate in medical ultrasound from the Chinese Academy of Medical Sciences & Peking Union Medical College, where she specialized in diagnostic imaging and clinical applications of ultrasound technologies. Her education emphasized understanding tumor biology and vascular physiology, equipping her with the skills to combine imaging innovation with clinical diagnostics. During her academic training, she focused on superb microvascular imaging, multiparametric ultrasound, and elastography to investigate the structural and functional characteristics of tumors. She gained experience in designing and implementing studies that integrate quantitative vascular indices with histopathological and molecular analyses. Her education provided a foundation for translational research, linking imaging findings to surgical and therapeutic outcomes. With rigorous training in both clinical ultrasound techniques and research methodology, Dr. Cai is well-prepared to advance precision diagnostics in oncology, particularly in the evaluation of gliomas and breast lesions, using state-of-the-art ultrasound modalities to enhance patient care.

Experience

Dr. Siman Cai is currently a resident doctor in medical ultrasound at Peking Union Medical College Hospital in Beijing, where she applies advanced ultrasound techniques in clinical practice. She has gained extensive experience performing intraoperative and diagnostic imaging for patients with brain tumors and breast lesions. Her work includes evaluating vascular architecture using superb microvascular imaging and shear-wave elastography to guide surgical decisions and improve diagnostic precision. Dr. Cai collaborates with multidisciplinary teams to integrate imaging findings into clinical workflows, contributing to accurate tumor grading, identification of molecular subtypes, and total tumor resection. She has also participated in clinical studies assessing quantitative vascular indices as predictive markers for tumor malignancy. Her professional experience bridges research and patient care, allowing her to implement novel imaging approaches in routine clinical practice and contribute to improving diagnostic efficiency and treatment outcomes. Her combined clinical and research expertise positions her as an emerging leader in ultrasound-based tumor diagnostics.

Awards and Honors

Dr. Siman Cai has been recognized for her innovative contributions to medical imaging and tumor diagnostics. Her work in superb microvascular imaging and shear-wave elastography has received attention in the oncology community for improving diagnostic accuracy in brain and breast tumors. She has contributed to multiple high-impact publications in respected journals, highlighting the clinical relevance of her research. Her achievements include advancing preoperative and intraoperative imaging approaches to support total tumor resection and precise tumor grading. Dr. Cai’s research has demonstrated the potential of ultrasound-based vascular indices as quantitative biomarkers for differentiating tumor malignancy and molecular subtypes. She is acknowledged for integrating cutting-edge imaging technologies into clinical practice, enhancing both research and patient care. Through her publications, clinical contributions, and innovative research methodologies, she has established herself as a promising expert in the field of ultrasound diagnostics and precision oncology, earning professional recognition among peers and mentors.

Research Focus

Dr. Siman Cai’s research focuses on applying advanced ultrasound imaging technologies to improve tumor diagnosis and treatment planning. She investigates the vascular architecture of gliomas and breast lesions using superb microvascular imaging, shear-wave elastography, and multiparametric ultrasound. Her work examines quantitative vascular indices, structural patterns, and microvascular features as diagnostic markers for differentiating benign and malignant tumors, identifying tumor boundaries, grading gliomas, and determining molecular subtypes. She explores intraoperative imaging techniques to assist total tumor resection and optimize surgical outcomes. Her research also evaluates the clinical value of integrating ultrasound-derived vascular indices with histopathology and molecular profiling. By bridging imaging innovation with clinical applications, Dr. Cai aims to enhance precision diagnostics and individualized treatment strategies. Her studies contribute to understanding tumor hemodynamics, improving diagnostic confidence, and providing non-invasive tools for monitoring tumor progression. Her ultimate goal is to advance ultrasound-based imaging as a reliable, accurate, and clinically actionable method in oncology.

 

Publications

 

Title: Role of Multiparametric Ultrasound in Predicting the IDH Mutation in Gliomas: Insights from Intraoperative B-Mode, SWE, and SMI Modalities
Year: 2025

Title: Clinical application of intraoperative ultrasound superb microvascular imaging in brain tumors resections: contributing to the achievement of total tumoral resection
Year: 2024

Title: Intraoperative shear-wave elastography and superb microvascular imaging contribute to the glioma grading
Year: 2023

Title: Association Between Vascular Index Measured via Superb Microvascular Imaging and Molecular Subtype of Breast Cancer
Year: 2022

Title: Relationship Between Serum Lipid Profiles and Carotid Intraplaque Neovascularization in a High–Stroke‐Risk Population: A Cross‐Sectional Study in China
Year: 2021

Conclusion

Dr. Siman Cai is an emerging expert in medical ultrasound, dedicated to advancing tumor diagnostics through innovative imaging technologies, translating research findings into clinical practice, and improving surgical precision and patient outcomes in neuro-oncology and breast cancer.

Yonghua Bi | Interventional Radiology | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Yonghua Bi | Interventional Radiology | Best Researcher Award

The First Affiliated Hospital of Zhengzhou University | china

Dr. Yonghua Bi is an accomplished Associate Chief Physician at the First Affiliated Hospital of Zhengzhou University, specializing in interventional treatment of tumors and vascular diseases. With a doctoral degree from China Medical University, Dr. Bi has dedicated his career to advancing minimally invasive procedures, pioneering research, and clinical innovation in interventional medicine. His work has contributed significantly to the understanding and management of vascular disorders, particularly arterial diseases. Author of over one hundred research articles, including more than eighty SCI-indexed papers, he has also published the book Stories of Interventional Radiology. Dr. Bi holds multiple patents, reflecting his commitment to translating research into practical solutions. As an active member and leader in professional societies, he plays an influential role in advancing interventional medicine in China. Recognized for his expertise, Dr. Bi also serves as a reviewer for esteemed journals, ensuring scientific rigor and promoting research excellence in his field.

Profile

ORCID

Education

Dr. Yonghua Bi earned his doctoral degree in medicine from China Medical University, where he developed a strong academic foundation in interventional medicine and vascular disease research. His education combined rigorous clinical training with in-depth research, enabling him to bridge theory and practice effectively. During his doctoral studies, he honed specialized skills in animal modeling, imaging techniques, and minimally invasive interventions, particularly focusing on vascular pathophysiology and therapeutic approaches. This academic background equipped him with a comprehensive understanding of both fundamental mechanisms and advanced clinical applications. His education emphasized interdisciplinary collaboration, integrating radiology, surgery, and pathology to optimize patient care. Exposure to both laboratory-based investigations and real-world clinical challenges shaped his ability to design research with practical implications. This robust educational journey laid the groundwork for his future contributions to innovation in interventional radiology and propelled him into leadership roles in academic medicine, research, and professional medical organizations.

Experience

Since joining the Department of Interventional Medicine at the First Affiliated Hospital of Zhengzhou University, Dr. Yonghua Bi has built a distinguished career combining patient care, research, and academic leadership. His clinical expertise spans interventional treatment for tumors and vascular diseases, with notable achievements in managing pulmonary embolism, deep vein thrombosis, and Budd-Chiari syndrome. He has pioneered work in abdominal aortic aneurysm modeling and regression studies, influencing both research and clinical protocols. As a prolific author, Dr. Bi has published extensively, contributing evidence-based advancements to interventional medicine. His role extends to mentorship, guiding young clinicians and researchers in advanced techniques and study design. He actively participates in academic societies, serving as standing director and youth committee leader in national medical associations. In addition, his editorial responsibilities include reviewing for reputable medical journals, ensuring scientific standards. His experience reflects a commitment to improving patient outcomes while advancing the frontiers of interventional radiology.

Awards and Honors

Dr. Yonghua Bi has earned recognition for his significant contributions to interventional medicine through awards, patents, and scholarly achievements. His approval of two invention patents and three utility model patents underscores his role as an innovator translating research into clinical solutions. His extensive publication record, with over eighty SCI-indexed articles as first or corresponding author, has positioned him as a leading voice in vascular disease research. The trust placed in him as a reviewer for the Clinical Journal of Medical Officers reflects his standing in the academic community. His leadership roles as standing director of the Interventional Medicine Branch of the Bethune Medical Research Society of China and deputy director of the Youth Committee of the Henan Medical Science Popularization Society demonstrate recognition by peers for his expertise and service. These honors collectively illustrate his influence in shaping the development, dissemination, and application of interventional medical knowledge in China and beyond.

Research Focus

Dr. Yonghua Bi’s research centers on interventional treatments for tumors and vascular diseases, with a particular emphasis on arterial and venous system disorders. His work in modeling abdominal aortic aneurysms in animals has provided valuable insights into disease mechanisms and potential regression pathways. This foundational research bridges basic science with clinical applications, informing innovative treatment strategies. Clinically, he focuses on complex vascular conditions such as pulmonary embolism, deep vein thrombosis, and Budd-Chiari syndrome, developing minimally invasive interventions that improve patient outcomes. His studies often integrate imaging advancements with procedural innovation, aiming for greater precision and reduced patient risk. Dr. Bi’s dual expertise in laboratory investigation and patient-centered care enables him to design interventions grounded in scientific evidence. Beyond direct treatment, his work seeks to expand the scope of interventional radiology, fostering multidisciplinary collaboration and training future specialists to advance the field through research-driven, patient-focused medical practice.

Publications

Title: Comparison between bougie and balloon dilation of benign esophageal strictures in infants and children.
Year: 2025

Title:Small Balloon Dilation Versus Bougie Dilation Versus Large Balloon Dilation for the Treatment of Benign Esophageal Strictures in Adult Patients.
Year:2025

Title: A comparison of three kinds of balloon dilatations for patients with benign esophageal strictures.
Year:2025

Title: Clinical evaluation of oxaliplatin-loaded drug-eluting callispheres beads transarterial chemoembolization for unresectable or recurrent esophageal carcinoma.
Year:2024

Conclusion

Dr. Yonghua Bi exemplifies the integration of clinical excellence, research innovation, and academic leadership in interventional medicine. His contributions to vascular disease modeling, minimally invasive treatment strategies, and high-impact publications have advanced both scientific understanding and patient care. Through patents, professional society leadership, and active editorial work, he has influenced medical practice and fostered the next generation of specialists. His career reflects a commitment to translating rigorous research into real-world applications, improving outcomes for complex vascular and oncological conditions. With a clear vision for advancing interventional radiology, he continues to drive progress in this rapidly evolving medical specialty.

Manijeh Beigi | Medical Physics | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Manijeh Beigi | Medical Physics | Best Researcher Award

Dr. Manijeh Beigi is an Assistant Professor in the Radiation Oncology Department at Iran University of Medical Sciences. She specializes in dosimetry, radiotherapy treatment planning, and quality audits, with a focus on using machine learning for radiomics and dosiomics analysis. Dr. Beigi earned her Ph.D. in Medical Physics from Tehran University of Medical Sciences in 2018, where she researched the application of Diffusion Tensor Imaging (DTI) in radiotherapy planning. With over a decade of experience in radiotherapy physics, she has worked in multiple hospitals, including Imam Hosein, Haft-e-Tir, and Pardis Niloo Cancer Center. She is actively involved in research on predicting radiotherapy toxicity and advanced MR imaging applications. Dr. Beigi has mentored numerous students, contributed to high-impact journals, and presented at international conferences. Her research aims to enhance radiotherapy precision and patient safety through cutting-edge imaging and AI-driven models. 🎓🔬

Profile

Education 🎓

Dr. Manijeh Beigi holds a Ph.D. in Medical Physics (2018) from Tehran University of Medical Sciences, where she developed automated clinical target volume determination for glioma treatment using multiparametric MRI. She completed her M.Sc. in Medical Physics (2010) at Tarbiat Modares University, focusing on radiotherapy dosimetry and quality audits in Varian linear accelerators. Her coursework covered key topics such as radiotherapy physics, radiobiology, MRI, CT, and PET physics, statistical methods, and treatment planning. Throughout her academic journey, she has specialized in advanced imaging techniques, radiomics, and AI-based predictive modeling for radiotherapy applications. Dr. Beigi’s education has provided her with strong expertise in medical physics, treatment planning optimization, and quality assurance, positioning her as a leader in radiation oncology research and innovation. 📚

Experience 👨‍🏫

Dr. Manijeh Beigi has been an Assistant Professor at Iran University of Medical Sciences since 2020, where she focuses on radiotherapy physics, treatment planning, and quality assurance. Previously, she worked as a Radiotherapy Physicist at Imam Hosein Hospital (2010-2016), Haft-e-Tir Hospital (2016-Present), and Pardis Niloo Cancer Center (2019-2021), specializing in 3D conformal radiotherapy, IMRT planning, machine QA, and dosimetry. She was also a Research Assistant (2012-2018) at Tehran University of Medical Sciences, collaborating on quantitative MRI and spectroscopy research. Dr. Beigi has significant experience in mentoring students, managing research projects, and implementing AI-driven radiotherapy solutions. Her work integrates imaging and machine learning to optimize treatment efficacy and minimize patient toxicity. 💼🔬

Research Interests 🔬

Dr. Manijeh Beigi’s research centers on dosimetry, radiotherapy quality audits, and the application of machine learning in radiomics and dosiomics. She explores AI-driven models to predict radiotherapy toxicity and optimize treatment planning. Her work integrates advanced MRI techniques, such as Diffusion Tensor Imaging (DTI), to enhance clinical target volume delineation for gliomas and other cancers. She investigates imaging biomarkers to assess radiation-induced damage and improve treatment precision. Additionally, Dr. Beigi is actively involved in multi-disciplinary research collaborations, utilizing deep learning for medical image analysis. Her contributions aim to advance radiation oncology by improving accuracy, reducing side effects, and personalizing treatment plans. 🧬📡

Dr. Manijeh Beigi has received several accolades for her contributions to medical physics and radiotherapy research. She has been recognized for her work in AI-driven radiomics and dosiomics at international conferences, including ESTRO and AAPM. Her research on glioma segmentation using DTI and radiotherapy toxicity prediction has been published in top-tier journals. She has also been awarded grants for her studies on advanced MRI applications in radiotherapy planning. Additionally, Dr. Beigi has played a key role in multi-institutional research collaborations, earning recognition for her leadership in medical imaging and quality assurance. 🏆🎖️

Publications 📚

Hongjun JIN | Nuclear Medicine Molecular Imaging | Interdisciplinary Innovation Prize

Published on by Cognitive Scientist Awards

Prof Dr.  Hongjun JIN | Nuclear Medicine Molecular Imaging | Interdisciplinary Innovation Prize

: Sun Yat-sen University Fifth Affiliated Hospital, china

Profile

Education

Dr. Hongjun Jin is a Principal Investigator in Nuclear Medicine and a Doctoral Supervisor of Molecular Medicine at Sun Yat-sen University. He earned his PhD in Biochemistry from Texas A&M University in 2007, following a BS in Radiochemistry from Lanzhou University in 1994 and a BMed in Chinese Medicine from Beijing University of Chinese Medicine in 1997. He completed his postdoctoral training at PNNL from 2008 to 2012 and served as a radiology instructor at Washington University in St. Louis from 2012 to 2017. Since 2017, he has led the PET and radiochemical laboratory at his institute, having been recruited through Sun Yat-sen University’s “Hundred Talents Program.”

Research and Innovations:

1) General Research Fund for National Sciences Foundation of China (NSFC), 82372004,
“F-18 labelled PET probe targeting P2X7 receptor for Evaluation of Treatment for AD”
01/01/2024-12/31/2027￥480,000,
2) Key R&D project, 0007/2022/AKP, Macao S&T Fund (FDCT),“R&D of an Integrated
Molecular probe for Targeted TNFR2 New Tumor Diagnosis and
Treatment”,01/01/2024-12/31/2027,￥2,400,000 (out of ￥120,000,000)
3) Guangdong Provincial Enterprise Joint Fund, 2021A1515220004, Guangdong Province
“PET/MRI Neuromolecular Imaging Quantitative Study of New Drug Targeting Sigma1

Research Project

  • 1) Outstanding Foreign Young Scientist Talent Program, RFIS, 82150610508 NSF-CN，
    “ Establishment and drug evaluation of acetylcholinergic and dopaminergic
    neuromolecular probes (18F VAT and 18F-DTBZ) PET brain imaging quantitative
    system for Parkinson’s disease” 2022/01-2022/12，￥400,000
  • General Research Fund for NSFC, 81871382, “F-18 labelled PET probe targeting P2X7
    receptor for early detection of AD”01/01/2019-12/31/2022￥570,000
  • SYSU “Hundred Talent “Starting Fund (Period I)” SYSU-FA10/01/2017-09/30/2022
    ￥2,500,000
  • National Key R&D Program for Precision Medicine, 2018YFC0910601 Real-time, highdimensional, multi-modality imaging co-registration and theronoastic strategies for
    oesophageal squamous-cell carcinomas10/01/2018-12/31/2020￥1,272,500 (out of
    ￥19,230,000)
  • Sun Yat-sen University Military Industry Cultivation Project, 89000-18843403 SYSU
    “Key Technologies of Molecular Imaging of Immune Dysfunction in Microgravity
    Environment”, 2019/08-2021/12￥1,890,00
  • Researchers Initiate Clinical Research Project (IIT) Award, SYSU-FAH”A single-center,
    open, prospective assessment of the diagnostic significance of 18F-FDG PET/CT
    dynamic imaging and gene sequencing in detecting metastatic lesions of non-small cell
    lung cancer”,2020/10-2021/09￥50,000
  • COVID-19 infection prevention and control emergency S&T, ZH22036302200036PWC,
    Zhuhai City”Specific Targeting S- protein of SARS-CoV-2 PET molecular imaging
    probe”2020/08-2021/09,￥70,000

Citation Index:

Google Scholar Citations: 8684 (total) 7943 (since 2020)
h-index 26(total) 20 (since 2020)
i10-index 52(total) 39(since 2020)

Publications